Care at NUH

Doctor Details

Find a Doctor
Doctor Detail

Dr Daniel Huang

Photo of Dr Daniel Huang


  • Consultant, Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital
  • Consultant, Adult Liver Transplantation Programme, National University Centre for Organ Transplantation, National University Hospital
  • Assistant Professor, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore


MBBS (S'pore), MMED (Int Med)(S'pore), MRCP (UK)



Clinical Disciplines/Programmes:

Adult Liver Transplantation Programme, Gastroenterology & Hepatology, Medicine, Organ Transplantation


Dr. Daniel Q. Huang graduated from the Yong Loo Lin School of Medicine, National University of Singapore. Presently, Dr. Huang is an Assistant Professor at the National University of Singapore and a transplant hepatologist at the National University Hospital. He leads hepatocellular carcinoma research in the Division of Gastroenterology.

Dr. Huang's research interest is in the early detection and prevention of hepatocellular carcinoma in non-alcoholic fatty liver disease and viral hepatitis. Dr. Huang is working on non-invasive strategies to detect and risk stratify chronic liver disease and hepatocellular carcinoma by leveraging advanced imaging-, genomic-, RNA-, meta-analytic-, and microbiome-based approaches. He has published more than 100 peer-reviewed articles, with first or corresponding author publications in journals such as Cell Metabolism, Gastroenterology, Hepatology, Nature Reviews Gastroenterology and Hepatology, the Lancet Gastroenterology and Hepatology, and the Lancet Oncology. He has received awards for his research from the American Association for the Study of Liver Diseases (AASLD), and the European Association for the Study of the Liver (EASL). Dr. Huang has been an invited speaker at the annual scientific meetings of the American Association for the Study of Liver Diseases (AASLD), the American Association for Cancer Research (AACR), and the Asia Pacific Association for the Study of the Liver (APASL). He currently serves on the editorial board of Alimentary Pharmacology and Therapeutics

Areas of Interest:

  • Hepatocellular carcinoma
  • Nonalcoholic fatty liver disease
  • Cirrhosis
  • Non-invasive tests for fibrosis and steatosis
  • Chronic hepatitis B

Journals & Publications

  1. Huang, D. Q., Singal, A. G., Kono, Y., et al. (2022). Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer. Cell Metabolism, 34(7), 969-977.e2. doi:10.1016/j.cmet.2022.05.003
  2. Huang, D. Q., Wilson, A.W, Behling, C. et al. Fibrosis Progression Rate in Biopsy-proven Nonalcoholic Fatty Liver Disease among People with Diabetes versus People without Diabetes: A Multicenter Study. Gastroenterology (2023).
  3. Tan, D. J. H., Ng, C. H.,.,. . . and Huang, D. Q. (2022). Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis. The Lancet Oncology, 23(4), 521-530. doi:10.1016/S1470-2045(22)00078-X
  4. Huang, D. Q., Fowler, K. J., Liau, J., et al. (2022). Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: A prospective study. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 55(7), 820-827. doi:10.1111/apt.16844
  5. Huang D.Q., Terrault NA, Tacke F, et al. Global epidemiology of cirrhosis - aetiology, trends and predictions. Nat Rev Gastroenterol Hepatol. 2023 Mar 28:1-11. doi: 10.1038/s41575-023-00759-2.
  6. Huang D.Q., Tran A, Yeh ML, et al. Antiviral therapy substantially reduces hepatocellular carcinoma risk in chronic Hepatitis B patients in the indeterminate phase. Hepatology. 2023 May 16. doi: 10.1097/HEP.0000000000000459.
  7. Huang D.Q., Nourredin N, Ajmera V, et al. Type 2 Diabetes Mellitus, Hepatic Decompensation and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease: Individual Participant Data Meta-analysis. The Lancet Gastroenterology and Hepatology 2023 (in press).
  8. Huang D.Q., Sharpton SR, Amangurbanova M, et al. Clinical Utility of Combined MRI-PDFF and ALT Response in Predicting Histologic Response in Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2022 Sep 6:S1542-3565(22)00832-1. doi: 10.1016/j.cgh.2022.08.036.
  9. Zheng M, Huang D.Q., Konkwo C, et al. Genomic analysis of lean individuals with NAFLD identifies monogenic disorders in a prospective cohort study. JHEP Rep. 2023 Feb 2;5(4):100692.
  10. Huang, D. Q., Muthiah, M. D., Zhou, L et al. (2021). Predicting HCC Response to Multikinase Inhibitors With In Vivo Cirrhotic Mouse Model for Personalized Therapy. Cellular and Molecular Gastroenterology and Hepatology, 11(5), 1313-1325. doi:10.1016/j.jcmgh.2020.12.009

Professional Memberships

  • Gastroenterological Society of Singapore (GESS)
  • American Association for the Study of Liver Diseases
  • Fellow of the Royal College of Physicians (UK)

Last updated on
Best viewed with Chrome 79.0, Edge 112.0, Firefox 61.0, Safari 11
National University Health System
  • National University Hospital
  • Ng Teng Fong General Hospital
  • Alexandra Hospital
  • Jurong Community Hospital
  • National University Polyclinics
  • Jurong Medical Centre
  • National University Cancer Institute, Singapore
  • National University Heart Centre, Singapore
  • National University Centre for Oral Health, Singapore
  • NUHS Diagnostics
  • NUHS Pharmacy
  • Yong Loo Lin School of Medicine
  • Faculty of Dentistry
  • Saw Swee Hock School of Public Health
Back to Top